Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951274 · ClinicalTrials.gov registry record · Phase 2
VPD-737 for Treatment of Chronic Pruritus
A Phase 2 study, sponsored by Vyne Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 257
- Enrollment target
NCT01951274 is a Phase 2 study that has completed, run by Vyne Therapeutics. The registered enrollment target is 257 participants.
The verdict
NCT01951274, a Phase 2 study, has completed, sponsored by Vyne Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 257 participants
- Enrollment target
Study Summary
A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments
Interventions
- DRUG Placebo
- DRUG VPD-737
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2013-10-15 |
| Est. Completion | 2014-12-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01951274
The ClinicalTrials.gov registry entry for NCT01951274 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vyne Therapeutics, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01951274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01951274 about?
NCT01951274 is a clinical study titled "VPD-737 for Treatment of Chronic Pruritus". A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments
What is the current status of trial NCT01951274?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 257 participants. The study started on 2013-10-15. Estimated completion is 2014-12-02.
What interventions are being tested in trial NCT01951274?
The interventions under investigation include: Placebo (DRUG), VPD-737 (DRUG).
Who is sponsoring clinical trial NCT01951274?
This trial is sponsored by Vyne Therapeutics, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.